Jagsonpal Pharmaceuticals Limited
NSE: JAGSNPHARM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Manish Gupta
- Employees
- 1,025
- Headquarters
- Gurugram, India
- IPO year
- 2002
- Market cap
- ₹14.6B
- Website
- https://www.jagsonpal.com
Loading JAGSNPHARM…
Loading profile data…Frequently asked questions about JAGSNPHARM
What does Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) do?
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and wo...
Where does JAGSNPHARM.NS trade?
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) trades on the National Stock Exchange of India.
What sector is JAGSNPHARM.NS in?
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jagsonpal Pharmaceuticals Limited?
Manish Gupta is the chief executive officer of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS).
Where is Jagsonpal Pharmaceuticals Limited headquartered?
Jagsonpal Pharmaceuticals Limited is headquartered in India.
Does JAGSNPHARM.NS pay a dividend?
Yes — Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) paid a trailing twelve-month dividend of INR 2.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did JAGSNPHARM.NS go public?
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) completed its initial public offering in 2002.